We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$74.6B
AUM Growth
+$361M
Cap. Flow
+$933M
Cap. Flow %
1.25%
Top 10 Hldgs %
22.45%
Holding
1,544
New
117
Increased
770
Reduced
482
Closed
138

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Technology 17.01%
3 Industrials 12%
4 Healthcare 10.22%
5 Energy 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YARW
1376
Yarrow Bioscience, Inc. Common Stock
YARW
$25.2M
$42K ﹤0.01%
+73
New +$43.4K
INO icon
1377
Inovio Pharmaceuticals
INO
$70M
$41K ﹤0.01%
949
IVR icon
1378
Invesco Mortgage Capital
IVR
$761M
$40K ﹤0.01%
1,774
-2,953
-62% -$72.7K
SRNE
1379
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$40K ﹤0.01%
17,130
+2,024
+13% +$6.31K
CTMX icon
1380
CytomX Therapeutics
CTMX
$729M
$35K ﹤0.01%
+13,240
New +$50.8K
PBYI icon
1381
Puma Biotechnology
PBYI
$407M
$35K ﹤0.01%
+12,164
New +$31.5K
OCGN icon
1382
Ocugen
OCGN
$434M
$34K ﹤0.01%
+10,369
New +$36.4K
SENS icon
1383
Senseonics Holdings Inc
SENS
$270M
$30K ﹤0.01%
760
+72
+10% +$3.3K
ENDP
1384
DELISTED
Endo International plc
ENDP
$30K ﹤0.01%
12,924
-1,435
-10% -$4.21K
VSTM icon
1385
Verastem
VSTM
$516M
$29K ﹤0.01%
1,702
CYCN icon
1386
Cyclerion Therapeutics
CYCN
$15.4M
$28K ﹤0.01%
+1,265
New +$30.5K
NEUE
1387
DELISTED
NeueHealth
NEUE
$28K ﹤0.01%
+181
New +$40.2K
IDEX
1388
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$28K ﹤0.01%
200
+21
+12% +$2.68K
CLSD
1389
DELISTED
Clearside Biomedical
CLSD
$27K ﹤0.01%
+784
New +$23.5K
GERN icon
1390
Geron
GERN
$1.05B
$22K ﹤0.01%
16,451
GTE icon
1391
Gran Tierra Energy
GTE
$334M
$22K ﹤0.01%
+1,395
New +$17.1K
DFTX
1392
Definium Therapeutics
DFTX
$5.89B
$22K ﹤0.01%
1,279
MMAT
1393
DELISTED
Meta Materials Inc. Common Stock
MMAT
$21K ﹤0.01%
+125
New +$23.3K
VBIV
1394
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$17K ﹤0.01%
335
AKBA icon
1395
Akebia Therapeutics
AKBA
$346M
$16K ﹤0.01%
21,863
+583
+3% +$1.25K
TOON icon
1396
Kartoon Studios
TOON
$35.1M
$16K ﹤0.01%
1,554
VTGN icon
1397
VistaGen Therapeutics
VTGN
$12.2M
$13K ﹤0.01%
346
DRRX
1398
DELISTED
DURECT Corp
DRRX
$8K ﹤0.01%
1,243
ASXC
1399
DELISTED
Asensus Surgical, Inc.
ASXC
$8K ﹤0.01%
12,654
CARM
1400
DELISTED
Carisma Therapeutics
CARM
$7K ﹤0.01%
539

Similar funds

Mackenzie Financial's Q1 2022 Portfolio in Review

As of Q1 2022, Mackenzie Financial held 1,544 positions worth $74.6B, up 0.49% from $74.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial's Q1 2022 filing shows 117 new, 770 increased, 482 reduced and 138 closed positions. Its largest new stake was Petco: 6,583,717 shares worth $129M. The largest sale was Microsoft, an estimated $321M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q1 2022 buy was Petco: 6,583,717 shares worth $129M.
  • Mackenzie Financial added most to Canadian National Railway in Q1 2022, an estimated $350M increase.
  • Mackenzie Financial's biggest Q1 2022 reduction was Microsoft, cutting an estimated $321M.
  • Mackenzie Financial fully exited Ralph Lauren in Q1 2022, selling an estimated $174M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $74.6B portfolio in Q1 2022.
  • Mackenzie Financial opened 117 new positions and closed 138 in Q1 2022.
  • Mackenzie Financial's portfolio value rose 0.49% quarter-over-quarter to $74.6B.

Based on Mackenzie Financial's 13F filing for Q1 2022, filed 13 May 2022.